Vera Therapeutics, Inc.·4

Apr 5, 9:27 PM ET

Grant Sean 4

4 · Vera Therapeutics, Inc. · Filed Apr 5, 2024

Insider Transaction Report

Form 4
Period: 2023-03-14
Grant Sean
CHIEF FINANCIAL OFFICER
Transactions
  • Gift

    Class A Common Stock

    2023-07-24+1,6201,620 total(indirect: As Custodian for UTMA account)
  • Gift

    Class A Common Stock

    2023-07-241,62018,657 total(indirect: By Trust)
  • Gift

    Class A Common Stock

    2023-03-14+14,28515,277 total(indirect: By Trust)
  • Gift

    Class A Common Stock

    2023-03-1414,28535,648 total
  • Gift

    Class A Common Stock

    2023-12-2063618,021 total(indirect: By Trust)
Holdings
  • Class A Common Stock

    (indirect: By Spouse)
    857
  • Class A Common Stock

    (indirect: By IRA)
    2,816
  • Class A Common Stock

    (indirect: By IRA)
    335
Footnotes (5)
  • [F1]Reflects the number of shares held directly at the time and after giving effect to the reported gift.
  • [F2]Reflects the number of shares held by the trust at the time and after giving effect to the reported gift.
  • [F3]Reflects the number of shares held by the trust at the time and after giving effect to the reported gift. The number also reflects a purchase reported on a Form 4 filed on June 23, 2023.
  • [F4]The shares were acquired through a custodial account established for an immediate family member of the Reporting Person pursuant to the Uniform Transfers to Minors Act, for which the Reporting Person serves as a custodian.
  • [F5]The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

Documents

1 file
  • 4
    form4-04062024_010432.xmlPrimary